Physician profile
Philo A Rogers
NPI 1841371572
$1,579.02
in general payments reported to CMS, 2019-2025
19 companies · $33.17 in 2025
The $33.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.00 · 2020: $130 · 2021: $409 · 2022: $706 · 2023: $289 · 2025: $33.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.84 | 2021-2023 | Viberzi, Linzess, Vraylar |
| Astrazeneca Pharmaceuticals LP | $270.17 | 2021-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.18 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $138.51 | 2020-2023 | Mounjaro, Trulicity, Jardiance |
| Novo Nordisk INC | $120.87 | 2020-2023 | Wegovy |
| Novartis Pharmaceuticals Corporation | $101.36 | 2021-2022 | |
| Angiodynamics, INC. | $89.87 | 2023 | Venacure 1470 Pro |
| Abbott Laboratories | $80.88 | 2021-2023 | Freestyle Libre 2 |
| Allergan, INC. | $55.61 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.34 | 2022-2023 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $34.94 | 2020-2022 | |
| Glaxosmithkline, LLC. | $28.12 | 2021-2025 | Shingrix |
| Amarin Pharma, INC. | $26.07 | 2020 | |
| Mylan Specialty L.P. | $18.20 | 2022 | |
| Exact Sciences Corporation | $18.19 | 2025 | The Cologuard Plus Collection Kit |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.57 | 2022 | |
| G Medical Diagnostic Services, INC. | $14.72 | 2022 | |
| Tactile Systems Technology INC | $12.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $11.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philo Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.